Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma Patients

Clinical trial NCT04164368 · COMPLETED

Trial details

NCT number: NCT04164368
Sponsor: Fudan University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Double Expressor Lymphoma

Start date: 2019-10-22
Primary completion: 2021-08-09
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.